TY - JOUR
T1 - Leadless pacing
T2 - a comprehensive review
AU - Saleem-Talib, Shmaila
AU - Hoevenaars, Crispijn P.R.
AU - Molitor, Nadine
AU - van Driel, Vincent J.
AU - van der Heijden, Jeroen
AU - Breitenstein, Alexander
AU - van Wessel, Harry
AU - van Schie, Mathijs S.
AU - de Groot, Natasja M.S.
AU - Ramanna, Hemanth
N1 - Publisher Copyright: © The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology.
PY - 2025/6/1
Y1 - 2025/6/1
N2 - Over the past decade, leadless pacing has undergone a rapid evolution, resulting in multiple leadless pacemaker (LPM) devices that offer advancements such as atrioventricular synchronized pacing in VDD mode, atrial stimulation, dual-chamber pacing, and longer battery longevity. Studies comparing LPMs with transvenous pacemakers (TVPMs) show a lower rate of device-related complications with LPMs. In the near future, LPMs could be combined with other devices such as non-transvenous implantable cardioverter-defibrillators to provide anti-tachycardia pacing or bradycardia pacing. Future prospectives for leadless cardiac resynchronization therapy and leadless conduction system pacing are being investigated. As LPMs continue to improve, their applications are anticipated to expand further improving patient outcome, promising a bright future for leadless pacing. In this review, the past, present, and future of leadless pacing are discussed with a focus on cutting-edge implantation techniques, clinical outcomes, and modern advancements of LPMs.
AB - Over the past decade, leadless pacing has undergone a rapid evolution, resulting in multiple leadless pacemaker (LPM) devices that offer advancements such as atrioventricular synchronized pacing in VDD mode, atrial stimulation, dual-chamber pacing, and longer battery longevity. Studies comparing LPMs with transvenous pacemakers (TVPMs) show a lower rate of device-related complications with LPMs. In the near future, LPMs could be combined with other devices such as non-transvenous implantable cardioverter-defibrillators to provide anti-tachycardia pacing or bradycardia pacing. Future prospectives for leadless cardiac resynchronization therapy and leadless conduction system pacing are being investigated. As LPMs continue to improve, their applications are anticipated to expand further improving patient outcome, promising a bright future for leadless pacing. In this review, the past, present, and future of leadless pacing are discussed with a focus on cutting-edge implantation techniques, clinical outcomes, and modern advancements of LPMs.
UR - https://www.scopus.com/pages/publications/105007145962
U2 - 10.1093/eurheartj/ehaf119
DO - 10.1093/eurheartj/ehaf119
M3 - Review article
C2 - 40105878
SN - 0195-668X
VL - 46
SP - 1979
EP - 1990
JO - European Heart Journal
JF - European Heart Journal
IS - 21
ER -